https://www.selleckchem.com/pr....oducts/nms-p937-nms1
eria for mania, and 3.8% of patients on adjunctive lurasidone therapy (n=497) met TEM criteria. Pediatric studies TEM rates were comparable in patients treated with lurasidone vs. placebo (1.7% vs. 2.3%). LS mean reduction in symptoms of mania from baseline to week 6 was significantly greater for lurasidone vs. placebo on YMRS score (-2.0 vs. -1.1; p0.05). Pediatric long-term studies After two years of OL treatment with lurasidone, 5.2% of patients met TEM criteria. Mean change in YMRS total score from DB baseline to Mon
Beğen
Yorum Yap
Paylaş
